Trial ID or NCT#

NCT01775774

Status

RECRUITING

Purpose

This is a Phase 1, open label, dose escalation, multi-center clinical trial of Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells (hMSCs) for the treatment of Acute Respiratory Distress Syndrome (ARDS). The purpose of this study is to assess the safety of hMSCs in patients with ARDS.

Investigator(s)

Contact us to find out if this trial is right for you.

CONTACT

Rosemary Vojnik
(650) 723-7409